chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a non-contactable physician's assistant and from a contactable physician reported through a Pfizer sales representative. A 20 year-old-female patient of an unspecified ethnicity received the second dose of TRUMENBA, at single dose and TDAP IPV, both via an unspecified route of administration on the same unspecified date. Medical history included diarrhea. Concomitant medication included Z-PAK for diarrhea. Two weeks prior the patient was traveling and she ended up getting diarrhoea episode, so she was ended up taking azithromycin there and then she was also scratched by rusty nail while she was there which caused her to bleed. By the time patient reached doctor office, it was healed up but patient's previous dose of diphtheria vaccine, pertussis vaccine, polio vaccine, tetanus vaccine was nine years before that, so that was why she got it again that day. Seven days after vaccinations, the patient experienced neck pain, jaw was hurting, felt weak, pain, lump in throat, chest pain, abdominal pain, fatigue, all with outcome of unknown. She ended up in ER (Emergency Room) on an unknown date, they did a spinal tap which came back with normal results. All events were assessed as non-serious. The reporting physician did not consider that meningococcal group b rlp2086 has causal effect to the adverse events. Follow-up (08-Aug-2016): New information from a contactable physician includes: reporter causality assessment. Follow-up attempts completed. No further information expected.
Faint, nauseous, tired  BP 143/102. My BP has always been good prior to the shot.
couldn't hold head up; no appetite; every bone in body hurt; chest hurt; hard to breathe; hair hurt; nauseated; migraine; low grade fever of 99 degrees, high grade fever of 102.5 degrees that lasted 9 day; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (migraine), HEAD DISCOMFORT (couldn't hold head up), DECREASED APPETITE (no appetite), BONE PAIN (every bone in body hurt) and CHEST PAIN (chest hurt) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B27A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Keflex), Allergy to antibiotic (erythromycin), Drug allergy (statins) and Drug allergy (steroid injection in joints). Concomitant products included ZOLPIDEM TARTRATE (AMBIEN), BUPROPION HYDROCHLORIDE (WELLBUTRIN), SERTRALINE HYDROCHLORIDE (ZOLOFT), METOPROLOL, TOPIRAMATE (TOPAMAX) and CLONAZEPAM (KLONOPIN) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced MIGRAINE (migraine) and PYREXIA (low grade fever of 99 degrees, high grade fever of 102.5 degrees that lasted 9 day). On 22-Mar-2021, the patient experienced HEAD DISCOMFORT (couldn't hold head up), DECREASED APPETITE (no appetite), BONE PAIN (every bone in body hurt), CHEST PAIN (chest hurt), DYSPNOEA (hard to breathe), PAIN OF SKIN (hair hurt) and NAUSEA (nauseated). The patient was treated with KETOROLAC TROMETHAMINE (TORADOL) on 03-Apr-2021 at an unspecified dose and frequency and PROCHLORPERAZINE EDISYLATE (COMPAZINE [PROCHLORPERAZINE EDISYLATE]) on 03-Apr-2021 at an unspecified dose and frequency. At the time of the report, MIGRAINE (migraine), HEAD DISCOMFORT (couldn't hold head up), DECREASED APPETITE (no appetite), BONE PAIN (every bone in body hurt), CHEST PAIN (chest hurt), DYSPNOEA (hard to breathe), PAIN OF SKIN (hair hurt), PYREXIA (low grade fever of 99 degrees, high grade fever of 102.5 degrees that lasted 9 day) and NAUSEA (nauseated) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, Body temperature: 99 (High) 99. On 22-Mar-2021, Body temperature: 102.5 (High) 102.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       0n 03-Apr-2021 the patient went to the emergency department and treatment included intravenous fluids.
1st dose in March 2020 didn´t get the 2nd dose yet; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in March 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not applicable to this report. Till the time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient asked should he/she get his/her second dose now or start over again with the first.
From telephone contact received at AP, it was reported that a 37 year old male patient received TDS ADS ADULT (Lot # U0530AA) on 10/04/2002 at 09:30AM. Within 1 hour after vaccination, the patient experienced arthralgia, body aches, dizziness, and rapid heart rate of 115 beats per minute.  Her blood pressure was within normal limits.  She was observed at the clinic and vital signs were stable.  Reportedly, the patient recovered fully from these adverse events.
Covid Pfizer 5-11yr vaccine given instead of  Covid Pfizer 12yr + vaccine.
5x5cm of induration, redness to left deltoid. Motrin for fever and/or pain
numbness to the face, congestion, eyes feeling funny. given 25mg PO Benadryl and Pepcid 10mg tablet X1. vitals stable x3 .BP 170's HR 50-70s. O2sat 92-98% no SOB no angioedema, no hives, no lip swelling, no tongue swelling no chest tightness.
Very itchy eyes about 7 hours after vaccine along with one hive on face. Resolved within an hour.
Next day swelling and redness.  Increased since then until a few days ago it became stable.  She has not tried anything to help.   It is painful, mild itching.  No fevers or chills, no headache.  NO sob, swelling of throat or tongue.  No known allergies in general.   She will use ICE and benadryl. Would use other arm for next vaccination and advise staff your provider recommended a 30 min stay vs 15.   ER if develop any SOB or tongue/throat swelling.
After taking the shot, I was ordered to sit and wait 15 minutes on the site. I got a bottle of water.    Then I was allowed to return to work, as I started driving my car, I felt the left half of the face a num feeling. The area from the eye to the chin, my skin could not sense much.    Half the facial muscles were stiff.  A doctor who has been examined was told that it may have caused sinusitis and prescribed allergic drug, Loratadine 5mg/Pseudoephedrine Sulfate 120mg.
1 wk post vax pt woke up w/arm pain @ inject site, tenderness under arm lt, aching all over body, backache, dizziness, & nausea; Seen by MD given ATB & bedrest; 2 days later seen @ clinic lt upper arm very edematous, hard, tender & warm;
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported. On 18-APR-2016, the patient was inadvertently vaccinated with improperly stored GARDASIL 9 injection lot # L020015 with expiry date 16-AUG-2017 or lot# reported as L006546 with expiry date 27-NOV-2017 (dose, route of administration and anatomical location were not specified. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information is not expected as there was no consent for further contact.
pt recvd vax;began v;became cyanotic;MD visit,lethargic,hypotonic,hyporesponsive,"waxy" in appearance;adm to hosp;improved 2-3 hrs later;fever 101 21apr;irritability;22apr recovered
cyst near their neck; This spontaneous case was reported by a nurse and describes the occurrence of CYST (cyst near their neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CYST (cyst near their neck). At the time of the report, CYST (cyst near their neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter.  Nurse reported that one person in her job has a has cyst near their neck after vaccination but couldn't provided information regarding the vaccines they took or personal information. Other vaccination given within 1 month prior to Moderna COVID-19 vaccine were unknown.  Treatment information was not provided.   This case was linked to MOD-2022-500447 (Patient Link).
Moderna COVID-19 vaccine EUA.  Needle loose on syringe, approximately 1/2 of dose not injected and dripped down patient's arm.
Urinary and intestinal issue 3 days after 1st dose of phizer vaccine for COVID lost feeling in bladder and intestines. Started getting better after 3 weeks. Got my 2nd dose 6 weeks after first because I wanted symptoms to get way better first and I didn't pee for like 17 hours. Thankfully most of the feels is back.
The patient who took the Moderna Covid vaccine and reported trouble swallowing afterwords; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (The patient who took the Moderna Covid vaccine and reported trouble swallowing afterwords) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPHAGIA (The patient who took the Moderna Covid vaccine and reported trouble swallowing afterwords). At the time of the report, DYSPHAGIA (The patient who took the Moderna Covid vaccine and reported trouble swallowing afterwords) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by reporter. No treatment medication was provided by reporter.
Red, sore swollen arm. Months later, I still can't raise my arm all the way or have blood pressure taken in that arm.
PATIENT RECEIVED MODERNA COVID19 VACCINE. AFTER IT WAS ADMINISTERED HE WAS ABLE TO GET UP AND WALK OVER TO THE DESIGNATED WAITING AREA APPROXIMATELY 5 MINUTES AFTER HE FAINTED AND FELL TO THE GROUND FROM A SEATED POSITION IN THE CHAIR. WHEN I GOT TO HIS SIDE I WAS UNABLE TO TURN OVER DO TO HIS SIZE BUT LESS THAN 30 SEC HE CAME TO AND WAS ABLE TO PICK HIMSELF UP BACK TO SEATED POSITION. PATIENT REPORTED NO INJURIES DUE TO THE INCIDENT.
Nearly immediate flushing of face and neck which mostly resolved.  Minimal flushing present 1.5 hours post-vaccination. Itching also present and ongoing.
Headache, CoughWheeze, Syncope, POSITIVE COVID Test on 7/28/2021 Narrative: POSITIVE COVID test 7/28/2021
Painful, slightly raised/tight area of skin. 4inch diameter circle around injection site that formed 18 hours after second dose of Moderna.  Both injections were received in the left arm.
One month after my 2nd Pfizer vaccine I began experiencing tremors. About 3 weeks after that I began experiencing seizure-like activity, worsening tremors, muscle spasms, memory difficulty, and dizziness.
2-3" diameter erythema, slight swelling no induration, no pain on palpation.
Pt received second dose of Hep A 5 months to soon. Pt is needing to finish series 6 months from last dose given. Pt did not have adverse reaction to vaccine.
Today (10-16-18) patient telephoned Medical Center to report that eight hours after receiving influenza vaccination on 10-12-18  his lower lip swelled. Never any airway or tongue distress. He also wants the package insert mailed to him. He declined offer of medical care. He stated he is normal today except for a few scabs on his lower lip that are healing. His lip is normal size now.
had body aches all day off; Had Runny nose and has been coughing; Had Runny nose and has been coughing; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (had body aches all day off), COUGH (Had Runny nose and has been coughing) and RHINORRHOEA (Had Runny nose and has been coughing) in an 81-year-old male patient who received mRNA-1273 (MODERNA COVID-19 VACCINE, (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination.     No Medical History information was reported.        No concomitant medication were reported.  It was reported that patient was still considered taking another dose of treatment medication.
My left arm is hot like on fire and with extreme itching. It?s very hard around the area of injection and is very red.
Student c/o vertigo after receipt of FLUMIST. Kept in observation area with legs elevated. State she felt condition improved 15'' later. Went to school nurse at 10AM - c/o "pressure in head". Vitals within normal range. Left & came back at 11:30, c/o HA - nurse gave her 2 ADVIL, BP 124/78 T98.3. Nurse asked her if she wanted to go home. Student said "no". Student texted parent sometime later. Parent picked student up & student signed self out of school.
Swollen jaw and throat, difficulty swallowing, high blood pressure Treated with intravenous Benadryl on site  Taken by ambulance to hospital where additional medication given Bloodwork, X-rays of lungs taken  Monitored for 2 hrs and released to husband with epi-pen and prednisone prescription
His D-dimer is a little elevated; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: FIBRIN D DIMER INCREASED (non-serious), outcome "unknown", described as "His D-dimer is a little elevated". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of fibrin d dimer increased.  Additional information: The patient reported that he and his wife had COVID about two to three weeks ago. Since then he has had Long COVID; consisting of a low grade fever, heavy chest, not pain or anything, just heavy breathing. He had a chest x ray and that looked fine. His D-dimer is a little elevated. He has a CT angiogram on 11Oct2023. He is on a blood thinner now just in case. He was fully vaccinated, no problems with that, boosters and everything with that, he was just waiting for this new one to come out and he got COVID.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300314987 same patient, different vaccine dose/AE;
Severe joint pain.  Started in hands, fingers, wrist day one.  Day 2 ankles. Day 3 extended to shoulders.
4:00 pm on 7/18/14 pt had fever 100.1 and developed "jerking" movements. Dr administered BENADRYL IV push in ER with pt completely symptom free in 2 hours.
Patient started itching on left arm on 08/25/19. Today, patient noticed red, inflamed area on arm moving down left arm. Called pharmacy and pharmacist told patient to come in for it to be examined. Appears to be injection site reaction starting at site of injection moving down patient's arm. Warm to the touch. Patient's physician was notified. Nurse stated to have us draw a line around the red area and to instruct the patient to take diphenhydramine and the nurse would follow-up. Pharmacist did do so and made recommendation to take diphenhydramine. Patient is aware to contact physician's office if swelling moves outside of marked lines and if the nurse did not reach out to her in within 2 days.
8/4/11 8:30 A parent reports client with elevated temp <101 degrees F and increased anxiety. Stated also has soreness at site and general flu-like symptoms ("crabby"). 8/4/11 3:15 pm: spoke with client who reports no further issues/resolved.
First 10 minutes felt cold, headache and numbness in both legs. Tingling in legs and headache remained for 30 minutes. But then indicated felt much better after 30 minutes. Patient also stated that he felt he needed to urinate right away. Patient stated he is blood pressure medications and did not take his medications the morning of the vaccine administration.   Pre administration BP 143/76 and Pulse 92  Post administration BP 235/135
high fever; severe local reaction; This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number XC534, expiry date unknown) for prophylaxis.   On 14th April 2018, the patient received the 1st dose of Shingrix. In April 2018, 2 days after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the patient experienced fever. In April 2018, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain and fever to be related to Shingrix.  Additional details were provided as follows: The physician reported that a patient experienced a severe local injection site reaction with soreness about two days after receiving her first dose of Shingrix. The soreness lasted about a week. The patient also experienced a high fever for a few days. All of the symptoms had resolved. Since the patient also has not received the second dose yet, this would make the patient late for her second dose. The reporter had consented to follow up. The case has been linked to case US2019107258, reported by same reporter.
Pt vax w/ Recombivax (2 doses) & Engerix-B (i dose) & no measurable titers were obtained.  2nd series given w/ Engerix-B & antibody response was neg.
Report A0365865A describes a local injection site reaction in a 34 year old female who inadvertently received hep A vaccine. There was no relevant medical history, concurrent conditions, or concurrent medications. On 3/7/02, the vaccinee inadvertently received Havrix IM, rather than purified protein derivative fo tuberculin. She experienced a local injection site reaction which resolved (date not specified).
Severe reaction to steroids injections; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ADVERSE REACTION (Severe reaction to steroids injections) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 039k20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder. Concomitant products included LEVOTHYROXINE for Thyroid disorder, LOSARTAN for an unknown indication.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced ADVERSE REACTION (Severe reaction to steroids injections). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 02-Feb-2021, ADVERSE REACTION (Severe reaction to steroids injections) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication reported included another pills for thyroid.  On 02 Feb 2021 the patient put two steroids injections, half an hour later she had a severe reaction to both injections. It was pretty severe reaction. Her doctor told her it was extremely weird to have a reaction to steroids. She think probably if related the covid-19 vaccine that maybe attack her immune system and produce this reaction.
body aches; headaches; weak for 2 days; dose number=3; dose number=3; This is a spontaneous report from a contactable consumer (patient). A 51-years-old non-pregnant female patient received booster dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: ff8839, patient was not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 04Oct2021 at 16:45 (at the age of 51-year-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number was not reported, patient was not pregnant at the time of vaccination), via an unspecified route of administration, on 20Jan2021 (at the age of 50-year-old) as DOSE 2, SINGLE; second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number was not reported, patient was not pregnant at the time of vaccination), via an unspecified route of administration, on 30Dec2020 (at the age of 50-year-old) as DOSE 1, SINGLE both for covid-19 immunisation. No other vaccine received in four weeks. No covid prior vaccination and no covid tested post vaccination. On 04Oct2021, the patient experienced dose number=3, on 05Oct2021 patient experienced body aches, headaches, weak for 2 days. No treatment received for events. The outcomes of events (body aches, headaches, weak for 2 days) were recovering.  Follow-Up (15Oct2021): Follow-up attempts are completed. No further information is expected.
painful local reaction at the injection site; painful local reaction at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (painful local reaction at the injection site) and VACCINATION SITE PAIN (painful local reaction at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (painful local reaction at the injection site) and VACCINATION SITE PAIN (painful local reaction at the injection site). At the time of the report, VACCINATION SITE REACTION (painful local reaction at the injection site) and VACCINATION SITE PAIN (painful local reaction at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.
Diarrhea, fever, chills, body aches, headache, lethargy, increased heart rate period lasted for 18 hours